ATE208041T1 - A-protein als diagnostikum für krebs - Google Patents

A-protein als diagnostikum für krebs

Info

Publication number
ATE208041T1
ATE208041T1 AT96902593T AT96902593T ATE208041T1 AT E208041 T1 ATE208041 T1 AT E208041T1 AT 96902593 T AT96902593 T AT 96902593T AT 96902593 T AT96902593 T AT 96902593T AT E208041 T1 ATE208041 T1 AT E208041T1
Authority
AT
Austria
Prior art keywords
protein
diagnostic
cancer
individual
antibodies
Prior art date
Application number
AT96902593T
Other languages
English (en)
Inventor
Geoffrey J Schmidt
Kenneth L Hoffman
Original Assignee
Schepens Eye Res Inst
Cytra Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schepens Eye Res Inst, Cytra Corp filed Critical Schepens Eye Res Inst
Application granted granted Critical
Publication of ATE208041T1 publication Critical patent/ATE208041T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT96902593T 1995-01-10 1996-01-11 A-protein als diagnostikum für krebs ATE208041T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37096995A 1995-01-10 1995-01-10
PCT/US1996/000098 WO1996021862A1 (en) 1995-01-10 1996-01-11 A-protein as a diagnostic of cancer

Publications (1)

Publication Number Publication Date
ATE208041T1 true ATE208041T1 (de) 2001-11-15

Family

ID=23461946

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96902593T ATE208041T1 (de) 1995-01-10 1996-01-11 A-protein als diagnostikum für krebs

Country Status (8)

Country Link
EP (1) EP0803065B1 (de)
JP (1) JPH10512369A (de)
CN (1) CN1168176A (de)
AT (1) ATE208041T1 (de)
AU (1) AU4694096A (de)
CA (1) CA2209823A1 (de)
DE (1) DE69616509D1 (de)
WO (1) WO1996021862A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187549B1 (en) * 1988-03-21 2001-02-13 Cytra Corporation Protein as a diagnostic of cancer
JP2003194775A (ja) * 2001-12-28 2003-07-09 Japan Science & Technology Corp タンパク質の電気泳動法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5405749A (en) * 1991-12-06 1995-04-11 Polans; Arthur S. Method for identifying and purifying a cancer associated retinopathy autoantigen, and testing patient serum for the autoantibody to the autoantigen
AU1873592A (en) * 1992-03-27 1993-11-08 Schepens Eye Research Institute, The Compositions and methods for regulating cellular signal transducing systems

Also Published As

Publication number Publication date
MX9705161A (es) 1998-10-31
CN1168176A (zh) 1997-12-17
CA2209823A1 (en) 1996-07-18
WO1996021862A1 (en) 1996-07-18
EP0803065A1 (de) 1997-10-29
DE69616509D1 (de) 2001-12-06
EP0803065B1 (de) 2001-10-31
AU4694096A (en) 1996-07-31
JPH10512369A (ja) 1998-11-24

Similar Documents

Publication Publication Date Title
DE3485920D1 (de) Kolorimetrisches immunoessay auf fester oberflaeche, sowie dazu zu verwendender teststab und seine herstellung.
ATE128237T1 (de) Test für hepatitis-c.
CA2214488A1 (en) Determination of cpsa
ATE258309T1 (de) Immunoassay-vorrichtung für diagnostische zwecke
EP0402846A3 (de) Fluoreszenzpolarisationsimmunoassay für Tetrahydrocannabinoide
ES511156A0 (es) Un metodo de determinar la presencia de un antigeno en un medio liquido sospechoso de contenerlo.
EP0346119A3 (de) Anti-FC-Test zum Nachweis von Antikörpern
DK0755517T3 (da) Fremgangsmåde til detektion af tilstedeværelse af en Mycobacterium-art og et kit og antistoffer til anvendelse i denne
ATE208041T1 (de) A-protein als diagnostikum für krebs
AU636964B2 (en) Immunological detection of metolachlor
MY106963A (en) Agglutination assay.
CA2213083A1 (en) Detection of antibody production
ES2122292T3 (es) Diagnosis precoz de sepsis utilizando interacciones antigeno-anticuerpo amplificadas por quimioluminiscencia de sangre completa.
ATE378601T1 (de) Diagnostischer test für menschlisches matrix gla- protein und seine verwendung als biomarker
ATE200353T1 (de) Kompetitiver immuntest unter verwendung komplexierter analytderivate
WO1998022825A3 (en) A whole blood/mitogen assay for the early detection of a subject with cancer and kit
ATE192236T1 (de) Menschliche phospholipase aktivierender proteinteil
ES8705232A1 (es) Un metodo para preparar un anticuerpo monoclonal destinado autilizarse como auxiliar de diagnostico para detectar cancerde pulmon
ATE256291T1 (de) Immunologische bestimmungsmethode
HUT60785A (en) Immunological measuring methods
NO881998D0 (no) Fremgangsmaate til kvantitativ bestemmelse av serumproteiner i kroppsvaesker, og middel til gjennomfoering av fremgangsmaaten.
ES2016992B3 (es) Reagente y procedimiento en la determinacion c 3a mediante ensayo inmunoquimico.
ES2070917T3 (es) Ensayo a base de cuantificacion de un enzima sobre una mecha.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties